Naglazyme 1 mg/ml concentrate for solution for infusion

Naglazyme is used to treat patients with MPS VI disease (Mucopolysaccharidosis VI). People with MPS VI disease have either a low level, or no level, of an enzyme called N-acetylgalactosamine 4-sulfatase, which breaks down specific substances... Mehr

Producer: BioMarin Europe Ltd.

Therapeutic group: Other alimentary tract and metabolism products

Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK